Top-News
Biotechnologie USA

Puma Biotechnology Inc Aktie

Aktie
WKN:  A1J643 ISIN:  US74587V1070 US-Symbol:  PBYI
3,10 $
+0,005 $
+0,16%
2,7367 € 17:39:59 Uhr
Depot/Watchlist
Aktienanzahl *
49,61 Mio.
Marktkapitalisierung *
139,25 Mio. €
Streubesitz
25,34%
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 17.03.2025

Puma Biotechnology Inc News

28.04.25 - Businesswire
Puma Biotechnology Presents Clinical Data on Neratinib at the AACR Annual Meeting 2025
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that clinical data on neratinib were presented in a poster session at the American Association ...
24.04.25 - Businesswire
Puma Biotechnology to Host Conference Call to Discuss First Quarter 2025 Financial Results
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PT/4:30 p.m. ET on Thursday, May 8, 2025, following the release of ...
02.04.25 - Businesswire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on April 1, 2025, the Compensation Committee of Puma’s Board of Directors approved ...
26.03.25 - Businesswire
Puma Biotechnology to Present Clinical Data on Neratinib at the AACR Annual Meeting 2025
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that clinical data on neratinib will be presented at the American Association for Cancer ...
05.03.25 - Businesswire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on March 4, 2025, the Compensation Committee of Puma’s Board of Directors approved ...
05.03.25 - Businesswire
Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder, will provide ...
05.03.25 - Businesswire
Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder, will provide ...
27.02.25 - Businesswire
Puma Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced financial results for the fourth quarter and year ended December 31, 2024. Unless otherwise ...
26.02.25 - Businesswire
Puma Biotechnology to Present at TD Cowen’s 45th Annual Health Care Conference
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder, will provide ...
13.02.25 - Businesswire
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PT/4:30 p.m. ET on Thursday, February 27, 2025, following the ...
05.02.25 - Businesswire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on February 4, 2025, the Compensation Committee of Puma’s Board of Directors ...
18.01.24 - PR Newswire
Thinking about buying stock in Marpai, Phunware, Spirit Airlines, BigBear.ai, or Puma Biotechnology?
Thinking about buying stock in Marpai, Phunware, Spirit Airlines, BigBear.ai, or Puma Biotechnology? PR Newswire
13.01.22 - PR Newswire
Thinking about buying stock in iSpecimen, Rockwell Medical, Puma Biotechnology, Bumble, or Nikola Corp?
Thinking about buying stock in iSpecimen, Rockwell Medical, Puma Biotechnology, Bumble, or Nikola Corp? PR Newswire
12.08.19 - PR Newswire
Cellulite Treatment Market Projected to Reach $1,438.5 Billion by 2026
Cellulite Treatment Market Projected to Reach $1,438.5 Billion by 2026 Financialnewsmedia.com News Commentary PR Newswire
18.06.18 - PR Newswire
Champions Oncology Partners with Puma Biotechnology and NSABP Foundation on Metastatic Breast and Colon Cancer Co-clinical PDX Studies
Champions Oncology Partners with Puma Biotechnology and NSABP Foundation on Metastatic Breast and Colon Cancer Co-​clinical PDX Studies PR Newswire
22.11.17 - PR Newswire
New Early- Breast Cancer Drug to be Made Available in Australia, New Zealand and South East Asia Following License Deal
New Early- Breast Cancer Drug to be Made Available in Australia, New Zealand and South East Asia Following License Deal - Specialised Therapeutics Asia to make NERLYNX® ...
03.10.17 - PR Newswire
Lifshitz & Miller LLP Announces Investigation of Equifax Inc., Intercept Pharmaceuticals, Inc., Inventure Foods, Inc., Puma Biotechnology, Inc., Tintri, Inc., Twenty-First Century Fox, Inc. and Ub
Lifshitz & Miller LLP Announces Investigation of Equifax Inc., Intercept Pharmaceuticals, Inc., Inventure Foods, Inc., Puma Biotechnology, Inc., Tintri, Inc., Twenty-​First Century Fox, Inc. ...
04.08.17 - PR Newswire
PUMA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Puma Biotechnology, Inc. - PBYI
PUMA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Puma Biotechnology, Inc. - PBYI ...
23.05.17 - PR Newswire
Options trade reports for BlackBerry, The Blackstone Group, MOMO Inc., Oracle Corporation and Puma Biotechnology include trade ideas that offer returns of 21% or more!
Options trade reports for BlackBerry, The Blackstone Group, MOMO Inc., Oracle Corporation and Puma Biotechnology include trade ideas that offer returns of 21% or more! PR ...
19.05.17 - PR Newswire
Harwood Feffer LLP Announces Investigation of Puma Biotechnology, Inc.
Harwood Feffer LLP Announces Investigation of Puma Biotechnology, Inc. PR Newswire

Newssuche

Videos

newspaper
30.04.25 +13,48%
Technical Trading: Cotton Long Chance
Cotton Long Typ: Turbo Open End WKN: VP6N8D Hebel: 3,80 Laufzeit: OpenEnd Einstieg: Market ... Mehr »